•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Verona Pharma Stock Jumps 21%. It's Being Bought for $10 Billion by Merck.
Merck to Buy Verona Pharma in $10 Billion Deal
Merck to acquire Verona Pharma for $10 billion
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025
My Top 10 High-Yield Dividend Stocks For July 2025: One Yields 12%-Plus
Merck & Co.: A Pharma Titan At A Discount
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Merck Mercuriadis plots return with new Hipgnosis venture after market rebound
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)
Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade
MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
Top 15 High-Growth Dividend Stocks For July 2025
Trading Rotation Kicks Off 2nd Half of 2025
Top 10 High-Yield Dividend Stocks For July 2025
Dividend Yield Theory Says Merck Is A Buy
Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.